April 3, 2018 — Following the unprecedented Gore REDUCE Clinical Study conclusion that closure of patent foramen ovale (PFO) can prevent recurrent ischemic strokes, W. L. Gore & Associates Inc. has received approval from the U.S. Food and Drug Administration (FDA) for an expanded indication for its Gore Cardioform Septal Occluder.Â
